This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Suzana Vega Harring: Innovator in Tumor Classification Technology
Introduction
Suzana Vega Harring is a notable inventor based in Starnberg, Germany. She has made significant contributions to the field of medical technology, particularly in tumor classification systems. Her innovative approach aims to enhance the accuracy of cancer treatment by utilizing advanced imaging techniques.
Latest Patents
Suzana holds a patent for a system titled "Distance-based tumor classification." This system is designed to receive at least one digital image of a patient's tissue sample. It analyzes the image to identify tumor cells and FAP+ areas, which represent cells expressing the fibroblast activation protein. The system computes a proximity measure based on the distances between tumor cells and their nearest FAP+ area. This measure is processed by a classifier to generate a classification result, indicating whether the patient's tumor can be treated with a drug that binds to FAP. Suzana's patent represents a significant advancement in personalized cancer treatment.
Career Highlights
Throughout her career, Suzana has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to develop and refine her innovative ideas in medical technology.
Collaborations
Suzana has collaborated with talented professionals in her field, including Fabien Gaire and Oliver Grimm. These partnerships have contributed to her success and the advancement of her projects.
Conclusion
Suzana Vega Harring is a pioneering inventor whose work in tumor classification technology is paving the way for more effective cancer treatments. Her contributions to the field are invaluable and demonstrate the potential of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
